Extracellular volume fraction mapping in the myocardium, part 1: Evaluation of an automated method

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Kellman, Peter ^a   Wilson, Joel R ^a   Xue, Hui ^b   Ugander, Martin ^c   Arai, Andrew E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b SIEMENS CORPORATE RESEARCH   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Co registration; Diffuse fibrosis; Edema; Extracellular; Late enhancement; Motion correction

Indexed keywords

ADULT; ARTICLE; AUTOMATION; BREATH HOLDING; EXTRACELLULAR SPACE; FEMALE; HEART FUNCTION; HEART MUSCLE; HEMATOCRIT; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MALE; MEASUREMENT; MYOCARDIAL EXTRACELLULAR VOLUME FRACTION; PRIORITY JOURNAL; WORKFLOW; AGED; ALGORITHM; CARDIOMYOPATHY; COMPARATIVE STUDY; FIBROSIS; FOLLOW UP; IMAGE ENHANCEMENT; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RETROSPECTIVE STUDY;

AGED; ALGORITHMS; CARDIOMYOPATHIES; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; RETROSPECTIVE STUDIES;

EID: 84865859137     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-63     Document Type: Article

References (27)

1. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Pennell DJ, Sechtem UP, Higgins CB, et al. EurHeart J 2004 25 1940 1965 (Pubitemid 39452612)
2. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. Hunold P, Schlosser T, Vogt FM, et al. Am J Roentgenol 2005 184 5 1420 1426 (Pubitemid 43821809)
3. Novel imaging techniques for diffuse myocardial fibrosis. Sado DM, Flett AS, Moon JC, Future Cardiol. 2011 7 5 643 650 10.2217/fca.11.45 21929344
4. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA, J Am Coll Cardiol 2011 57 8 891 903 10.1016/j.jacc.2010.11.013 21329834
5. T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison. Gai N, Turkbey EB, Nazarian S, et al. Magn Reson Med 2011 65 5 1407 1415 10.1002/mrm.22716 21500267
6. Myocardial T1 and Extracellular Volume Fraction Mapping at 3 Tesla. Lee JJ, Liu S, Nacif MS, Ugander M, Kawel N, Sibley CT, Kellman P, Arai A, Bluemke DA, J Cardiovasc Magn Reson 2011 13 1 75 10.1186/1532-429X-13-75 22123333
7. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar mr imaging to quantify myocardial infarction: Comparison with 99mtc-dtpa autoradiography in rats. Arheden H, Saeed M, Higgins CB, et al. Radiology 1999 211 698 708 10352594 (Pubitemid 29249466)
8. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Jerosch-Herold M, Sheridan DC, Kushner JD, et al. Am J Physiol Heart Circ Physiol 2008 295 1234 H1242 10.1152/ajpheart.00429.2008 18660445
9. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Flett AS, Hayward MP, Ashworth MT, et al. Circulation 2010 122 2 138 144 10.1161/CIRCULATIONAHA.109.930636 20585010
10. Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Kehr E, Sono M, Chugh S, Jerosch-Herold M, Int J Cardiovasc Imaging. 2008 24 61 68 17429755 (Pubitemid 350263105)
11. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Broberg CS, Chugh S, Conklin C, Sahn DJ, Jerosch-Herold M, Circ Cardiovasc Imaging. 2010 3 727 734 10.1161/CIRCIMAGING.108.842096 20855860
12. Myocardial Extracellular Volume Fraction Measurement by Gadolinium Cardiovascular Magnetic Resonance in Humans: Slow Infusion versus Bolus. Schelbert E, Testa SM, Meier CG, et al. J Cardiovasc Magn Reson 2011 13 16 10.1186/1532-429X-13-16 21375743
13. Extracellular Volume Imaging by MRI Provides Insight into Overt and Subclinical Myocardial Pathology. Ugander M, Oki AJ, Hsu L-Y, et al. Eur Heart J 2102 33 10 1268 1278
14. Edema by T2-weighted imaging in salvaged myocardium is extracellular, not intracellular. Ugander M, Bagi PS, Booker OJ, et al. J Cardiovasc Magn Reson 2011 13 Suppl 1 70 2 February 2011 22085467
15. Motion Correction for Myocardial T1 Mapping using Image Registration with Synthetic Image Estimation. Xue H, Shah S, Greiser A, et al. Magn Reson Med 2012 Jun 67 6 1644 55 10.1002/mrm.23153
16. Mechanism of late gadolinium enhancement in patients with acute myocardial infarction. Klein C, Schmal TR, Nekolla SG, Schnackenburg B, Fleck E, Nagel E, J Cardiovasc Magn Reson 2007 9 4 653 658 10.1080/10976640601105614 17578720 (Pubitemid 46956899)
17. Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J, J Magn Reson Imaging 2007 26 1081 6 10.1002/jmri.21119 17896383 (Pubitemid 47548170)
18. Myocardial extracellular volume imaging-phantom validation and patient feasibility for quantitative pixel mapping of the fractional distribution volume of extracellular contrast agents by MRI. Ugander M, Oki AJ, Kellman P, Greiser A, Aletras AH, Arai AE, Proceedings of the Joint Annual Meeting of ISMRM-ESMRMB Stockholm, Sweden 2010 Abstract #1305
19. Myocardial infarction: optimization of inversion times at delayed contrast-enhanced MR imaging. Gupta A, Lee VS, Chung YC, Babb JS, Simonetti OP, Radiology 2004 233 3 921 6 10.1148/radiol.2333032004 15516607
20. Quantification of Tl Values by SNAPSHOT-FLASH NMR Imaging. Deichmann R, Haase A, J Magn Reson 1992 612 608 612
21. Modified Look-Locker T(1) evaluation using Bloch simulations: Human and phantom validation. Gai ND, Stehning C, Nacif M, Bluemke DA, Magn Res Med 2012 [Epub ahead of print] 10.1002/mrm.24251
22. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Kellman P, Arai AE, McVeigh ER, Aletras AH, Magn Reson Med 2002 47 372 383 10.1002/mrm.10051 11810682 (Pubitemid 34116807)
23. Myocardial edema as detected by pre-contrast T1 and T2 MRI delineates area at risk associated with acute myocardial infarction. Ugander M, Bagi PS, Oki AJ, et al. JACC Cardiovasc Imaging 2012 5 6 596 603 10.1016/j.jcmg.2012.01. 016 22698528
24. Multi-echo Dixon Fat and Water Separation Method for Detecting Fibro-fatty Infiltration in the Myocardium. Kellman P, Hernando D, Shah S, et al. Magn Reson Med 2009 61 215 221 10.1002/mrm.21657 19097213
25. Myocardial Fat Imaging. Kellman P, Hernando D, Arai AE, Curr Cardiovasc Imaging Rep 2010 3 83 91 10.1007/s12410-010-9012-1 20401158
26. Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: Normal distribution and elevation in acute and chronic infarction. Flacke SJ, Fischer SE, Lorenz CH, Radiology 2001 218 703 710 11230643 (Pubitemid 32172551)
27. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3T within a 9 heartbeat breathhold. Piechnik SK, Ferreira VM, Dall'Armellina E, et al. J Cardiovasc Magn Reson 2010 12 69 10.1186/1532-429X-12-69 21092095